… in 49 patients with hepatocellular carcinoma or liver metastases. Our results highlighted
that cryoablation is an effective and safe method for the treatment of liver cancers that are not …

… managing hepatic metastases, and cryoablation is among them, … of percutaneous cryoablation
in all types of liver metastases. … of percutaneous cryoablation in treating liver metastases …

… -stage HCC, in accordance with the latest Barcelona Clinic Liver Cancer (BCLC) classification.
Because of its rich blood supply, the liver is also the most common site for metastasis. …

… cells than in LO2 cells when cryoablation was used with KCl … cryoablation and describe a
novel therapeutic model for the treatment of liver cancer that may distinguish between cancer …

… the expansion of cryoablation in the treatment of cancer. It … liver cancer, ultrasound imaging
guided cryoablation have been widely used in other cancer diseases, such as breast cancer …

… trial revealed that cryoablation is equally … cryoablation is advantageous in treating liver
tumors at high-risk locations (22–24). To date, data on the safety and effectiveness of cryoablation …

… tumors (50 liver metastases and 14 HCC) were treated with cryoablation under conscious …
cryoablation in 45 patients for early or very early stage HCC per Barcelona Clinic Liver cancer (…

… that patients with unresectable liver cancer, local HCC, tumors larger than 2 cm and one
or two tumors of no more than 4 cm who received cryoablation had similar survival benefits …

… Liver cancer is the fifth most common cancer and the second leading cause of cancer-related …
carcinoma (HCC) accounting for 90% of primary liver cancers [Citation1]. In addition, the …

… , lung cancer, liver cancer, gastric cancer, urothelial cancer and lymphoma (78). Blockade
of the CTLA-4 interaction site by antibodies to CTLA-4 allows CD80/86 ligands to be used with …